Scott Plesha

CEO

Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. (PTHS)

Board Member

Pelthos Therapeutics Inc. (PTHS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Pelthos Therapeutics Inc. (PTHS)
SEC 8-K

Current
2025-07-01–present
Pelthos Therapeutics Inc. (PTHS)
Board Member

Proxy statement

Current
2025-01-01–present
Pelthos Therapeutics Inc. (PTHS)
CEO

Proxy statement

Current

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Pelthos Therapeutics Inc.

PTHS

Current role

CEO, Board Member

2025-01-01–present

3 calls Latest call 2026-08-13

View earnings calls

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Pelthos Therapeutics Inc. (PTHS)	Chief Executive Officer	$219,802	$240,900	$1,129,653	$2,557,650	—	$5,163	$4,153,168
2024	Pelthos Therapeutics Inc. (PTHS)	Chief Executive Officer	—	—	—	—	—	—	—

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Earnings call Second Quarter 2026 Financial Results Call Pelthos Therapeutics Inc. (PTHS)
2026-08-13
Earnings call Pelthos Therapeutics Inc. Q1 FY2026 Earnings Call Pelthos Therapeutics Inc. (PTHS)
2026-05-14
Earnings call Pelthos Therapeutics Inc. Q3 FY2025 Earnings Call Pelthos Therapeutics Inc. (PTHS)
2025-11-13
Executive change Appointed: Chief Executive Officer Pelthos Therapeutics Inc. (PTHS)
2025-07-01
Executive change Appointed: director Pelthos Therapeutics Inc. (PTHS)
2025-07-01
Executive change Appointed: President Pelthos Therapeutics Inc. (PTHS)
2025-07-01